epilessija
F'mudell tal-ġurdien ta ' epilessija (Maxim Electro Shock), dan li ġej cannabinoids instabu li kienu anti-konvulsivi (ED50) (Devinsky et al., 2014): CBD 120 mg / kg Δ9THC 100 mg / kg 11-OH-Δ9THC 14 mg / kg 8β-OH-Δ9THC 100 mg / kg Δ9THCA 200-400 mg / kg Δ8THC 80 mg / kg CBN 230 mg / kg Δ9α / β-OH-hexahydro-CBN 100 mg / kg Barra minn hekk, id-dożi rrappurtati hawn fuq huma oerhört għoljin, ma tipprovdix prova ta 'prinċipju li ħafna cannabinoids jeżerċitaw effetti anti-konvulsivi.
Parkinson's
F'numri tan-newtral kulturali kkultivati, CBD, THCA u, THC kellu proprjetajiet anti-ossidattivi. Barra minn hekk, THCA u, THC intwerew li huma newroprotettivi (Moldzio et al., 2012).
Referenzi:
Devinsky, O., Cilio, MR, Cross, H., Fernandez-Ruiz, J., Franċiż, J., Hill, C., Katz, R., Di Marzo, V., Jutras-Aswad, D., Notcutt , WG, et al. (2014). Cannabidiol: farmakoloġija u rwol terapewtiku potenzjali f ' epilessija u disturbi newropsikjatriċi oħrajn. Epilessija 55, 791-802.
Moldzio, R., Pacher, T., Krewenka, C., Kranner, B., Novak, J., Duvigneau, JC, u Rausch, W.-D. (2012). Effetti ta ' cannabinoids Δ (9) -tetrahydrocannabinol, Δ (9) -tetrahydrocannabinolic acid u cannabidiol f'PPP + kulturi mesencephalic murine affettwati. Phytomedicine Int. J. Phytother. Phytopharm. 19, 819-824.
